Cardinal Health Inc (CAH) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Cardinal Health Inc (CAH) stock forecast summary
On Oct. 14, 2026, CAH is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 4004 stocks scored that day.
Cardinal Health Inc is a large-cap company with a market capitalization of $55.75B. It ranks number 3 by market capitalization among the 6 Wholesale-Drugs, Proprietaries & Druggists' Sundries issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for CAH is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, CAH included.
Follow CAH freeCAH price chart and AI forecast
How CAH ranks among 4004 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Cardinal Health Inc (CAH) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Wholesale-Drugs, Proprietaries & Druggists' Sundries peers listed below that report each metric.
Valuation & Market
| Metric | CAH | Rank |
|---|---|---|
| Market Cap | $55.75B | 3/6 |
| EPS | $8.23 | – |
Profitability & Margins
| Metric | CAH | Rank |
|---|---|---|
| ROA | 4.4% | 3/8 |
| Gross Margin | 3.2% | 7/7 |
| Operating Margin | 0.8% | 4/7 |
| Net Margin | 0.7% | 4/8 |
| EBT Margin | 0.7% | 4/8 |
| Tax Rate | 23.9% | – |
Financial Health
| Metric | CAH | Rank |
|---|---|---|
| Interest Coverage | 6.9x | 2/7 |
Cash Flow
| Metric | CAH | Rank |
|---|---|---|
| Operating Cash Flow | $6.70B | 2/8 |
| OCF Growth YoY | 127.4% | 2/5 |
Income Statement
| Metric | CAH | Rank |
|---|---|---|
| Operating Income | $3.04B | 2/7 |
| Net Income | $2.51B | 3/8 |
| SG&A Expense | $7.62B | 3/6 |
| Cost of Goods Sold | $302.43B | 3/8 |
Dividend & Shareholder Information
| Metric | CAH | Rank |
|---|---|---|
| Shares Outstanding | 233M | – |
Balance Sheet Highlights (USD millions)
| Total Liabilities | $60.02B |
CAH quarterly financials and insider trading
Cardinal Health Inc (CAH) industry peers
Companies classified under the same SEC industry code as Cardinal Health Inc (Wholesale-Drugs, Proprietaries & Druggists' Sundries): 8 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeWhere CAH sits on the market map
Cardinal Health Inc (CAH) stock news
Loading...
Cardinal Health Inc (CAH) stock forecast FAQ
What is the Cardinal Health Inc (CAH) stock forecast?
On Oct. 14, 2026, CAH is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 4004 stocks scored that day.
How accurate are Cardinal Health Inc stock predictions?
A per-ticker accuracy statistic for CAH is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Cardinal Health Inc forecasts updated?
Cardinal Health Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Cardinal Health Inc's industry peers?
8 issuers in our coverage, CAH included, share the SEC industry code Wholesale-Drugs, Proprietaries & Druggists' Sundries. The largest are: Mckesson Corp (MCK), Cencora, Inc. (COR), Herbalife Ltd. (HLF), Nu Skin Enterprises, Inc. (NUS), Hwh International Inc. (ESYN), Cosmos Health Inc. (COSM).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.